Staar Surgical Swings to $0.38 EPS Profit After Year-Ago $0.52 Loss
STAA•Staar reported Q1 EPS of $0.38, beating the $0.13 consensus and swinging from a year-ago loss of $0.52 per share. It issued a shareholder letter alongside first-quarter results highlighting operational advances and regained profitability.
1. Q1 Financial Performance
Staar Surgical reported Q1 adjusted EPS of $0.38, surpassing the $0.13 consensus and reversing a $0.52 loss from Q1 2025. Revenue growth outpaced expectations on stronger intraocular collamer lens demand and disciplined cost controls.
2. Shareholder Letter Highlights
The company issued a shareholder letter with its quarterly report, outlining strategic priorities such as expanding global distribution channels, advancing its R&D pipeline and pursuing operational efficiencies to sustain profitability.
